Zicronapine fumarate

Modify Date: 2024-04-06 17:40:49

Zicronapine fumarate structure	Common Name	Zicronapine fumarate
	CAS Number	170381-17-6	Molecular Weight	470.99
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₃₁ClN₂O₄	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Zicronapine fumarate

Zicronapine (Lu 31-130) fumarate is an antipsychotic medication with a strong pro-cognitive effect in animal models and the potential to treat a number of neurological and psychiatric diseases. Zicronapine (Lu 31-130) fumarate has potent antagonistic effects at dopamine D1/D2, and serotonin 5-HT2A receptors[1][2].

Name	Zicronapine fumarate

Description	Zicronapine (Lu 31-130) fumarate is an antipsychotic medication with a strong pro-cognitive effect in animal models and the potential to treat a number of neurological and psychiatric diseases. Zicronapine (Lu 31-130) fumarate has potent antagonistic effects at dopamine D1/D2, and serotonin 5-HT2A receptors[1][2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor
References	[1]. Lopez De Diego, Heidi. et al. Succinate and malonate salts of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and their preparation, pharmaceutical compositions, and use as medicaments, particularly as antipsychotics. WO2005016900A1 [2]. Lundbeck H. A/S. The clinical phase III programme commenced on zicronapine. 20 Jan 2011.

Description

Related Catalog

Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor

Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor

Research Areas >> Neurological Disease

Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor

Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor

References

[1]. Lopez De Diego, Heidi. et al. Succinate and malonate salts of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and their preparation, pharmaceutical compositions, and use as medicaments, particularly as antipsychotics. WO2005016900A1

[2]. Lundbeck H. A/S. The clinical phase III programme commenced on zicronapine. 20 Jan 2011.

Molecular Formula	C₂₆H₃₁ClN₂O₄
Molecular Weight	470.99

Zicronapine fumarate

Use of Zicronapine fumarate

Names

Zicronapine fumarate Biological Activity

Chemical & Physical Properties